May 4, 2022
Via: The Wall Street JournalModerna Inc. MRNA -1.16% said that its first-quarter revenue and profit tripled from a year earlier on higher sales of its Covid-19 vaccine and that a fall booster-shot campaign could drive continued sales gains. The biotechnology company’s revenue topped $6 […]
July 9, 2024
June 25, 2024